Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JM

Jesse A. May — 36 Patents

ALAlcon: 19 patents #23 of 866Top 3%
ALAlcon Laboratories: 10 patents #22 of 314Top 8%
AMAlcon Manufacturing: 5 patents #7 of 72Top 10%
ARAlcon Research: 1 patents #145 of 267Top 55%
YCYamanouchi Pharmaceutical Co.: 1 patents #277 of 516Top 55%
Fort Worth, TX: #28 of 2,247 inventorsTop 2%
Texas: #2,960 of 125,132 inventorsTop 3%
Overall (All Time): #92,222 of 4,157,543Top 3%
36 Patents All Time
Jesse A. May has been granted 36 US patents while listed as an inventor at Alcon. The first was granted in 1992 and the most recent in February 2010. Jesse A. May ranks #92,222 of 4,157,543 US inventors in our database (top 2.2%). Patent records list Jesse A. May in Fort Worth, TX, US.

Issued Patents All Time

Showing 1–25 of 36 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7655662 (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure Mark R. Hellberg, Najam A. Sharif, Andrew Rusinko, Hwang-Hsing Chen 2010-02-02 $392,542,000
7476687 Substituted furo[2,3-g]indazoles for the treatment of glaucoma Anura P. Dantanarayana 2009-01-13 $156,886,000
7439262 Substituted 1-alkylamino-1-H-indazoles for the treatment of glaucoma Anura P. Dantanarayana 2008-10-21 $230,900,000
7425572 Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma Hwang-Hsing Chen 2008-09-16 $346,912,000
7338972 Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma Anura P. Dantanarayana 2008-03-04 $242,394,000
7297505 Use of MDCK cell line to predict corneal penetration of drugs Andrew Rusinko, Mark R. Hellberg, Geoffrey R. Owen 2007-11-20 $103,806,000
7285553 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders Thomas R. Dean, Najam A. Sharif, Hwang-Hsing Chen 2007-10-23 $73,725,000
7268131 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma Anura P. Dantanarayana 2007-09-11 $64,768,000
D539293 Adjustable support arm for video monitor Gordon G. May 2007-03-27
7129257 Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma Anura P. Dantanarayana 2006-10-31 $232,748,000
7060704 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders Thomas R. Dean, Najam A. Sharif, Hwang-Hsing Chen 2006-06-13 $68,505,000
7012090 Pyranoindoles for treating glaucoma Hwang-Hsing Chen 2006-03-14 $206,287,000
7005443 5-Hydroxy indazole derivatives for treating glaucoma Zixia Feng 2006-02-28 $69,465,000
7005448 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma 2006-02-28 $69,465,000
6989445 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma Anura P. Dantanarayana 2006-01-24 $226,432,000
6960608 Fused indazoles and indoles and their use for the treatment of glaucoma Anura P. Dantanarayana 2005-11-01 $61,439,000
6960579 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders Thomas R. Dean, Najam A. Sharif, Hwang-Hsing Chen 2005-11-01 $61,439,000
6956036 6-hydroxy-indazole derivatives for treating glaucoma Zixia Feng, Anura P. Dantanarayana 2005-10-18 $122,406,000
6933392 Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma Paul W. Zinke 2005-08-23 $210,593,000
6927233 5ht2 agonists for controlling IOP and treating glaucoma Anura P. Dantanarayana 2005-08-09 $117,643,000
6884816 Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma Paul W. Zinke 2005-04-26 $218,354,000
6881749 Pyranoindazoles and their use for the treatment of glaucoma Hwang-Hsing Chen, Bryon Severns 2005-04-19 $100,821,000
6806285 5-Hydroxyl indole derivatives for treating glaucoma Paul W. Zinke 2004-10-19 $53,926,000
6696476 Pyranoindazoles and their use for the treatment of glaucoma Hwang-Hsing Chen, Bryon Severns 2004-02-24 $37,157,000
6664286 Serotonergic 5ht2 agonists for treating glaucoma Thomas R. Dean, Najam A. Sharif, Mark R. Hellberg 2003-12-16 $41,771,000